Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 22Phase 1/2 7Phase 3 6Phase EARLY_PHASE1 5Phase NA 4Phase 2/3 4Phase 4 2

Status

Completed 23Unknown 15Terminated 3Recruiting 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Wilms Tumor 1Breast Neoplasms 1

Interventions

Carboplatin 6anlotinib 5lenvatinib 4Oxaliplatin 4Immune Checkpoint Inhibitors 4Cisplatin 4tislelizumab 3sintilimab 3Fluorouracil 3Capecitabine 3venetoclax 2Rosuvastatin Calcium 2Prednisone 2Megestrol Acetate 2Leucovorin 2Drug Therapy 2Dexmedetomidine 2Dexamethasone 2Cyclophosphamide 2Bevacizumab 2Aspirin 2zanubrutinib 1xiaojin wan 1trastuzumab deruxtecan 1trametinib 1tocilizumab 1testosterone 17 beta-cypionate 1tenofovir alafenamide 1telitacicept 1taxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Cyclophosphamide × Clear all
NCT04137640 2021-07-20

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Shengjing Hospital

Phase 4 Not yet recruiting
152 enrolled
Breast

Breast Neoplasms

NCT03892330 2019-03-27

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Shengjing Hospital

Phase 4 Not yet recruiting
120 enrolled
Genitourinary

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡